US Stock MarketDetailed Quotes

ABEO Abeona Therapeutics

Watchlist
  • 4.9700
  • -0.0700-1.39%
Close Mar 28 16:00 ET
  • 5.0600
  • +0.0900+1.81%
Post 20:01 ET
241.21MMarket Cap-3.21P/E (TTM)

Abeona Therapeutics Key Stats

Abeona Therapeutics Q4 2024 Earnings Date

Currency:USDMar 20, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.35
-0.14
+0.21
Beat Est.
+44.69%
+78.13%
+60.44%
Net Income
--
-9.29M
--
+43.99%
Strong Buy

Mar 20, 2025

Abeona Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Mar 20, 20252024/Q40.000 / 83.330K--
Nov 14, 20242024/Q30.000 / 83.330K--
Aug 12, 20242024/Q20.000 / 83.330K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
Mar 20, 20252024/Q40.000 / 83.330K--
Nov 14, 20242024/Q30.000 / 83.330K--
Aug 12, 20242024/Q20.000 / 83.330K--

Unlock Free Earnings Estimates

Abeona Therapeutics Earnings Reports

Read more

Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 20, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data